Lilly eyes more cancer deals, but wary of CAR-T, gene therapy

  • 📰 Reuters
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 97%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Eli Lilly and Co remains in the hunt for cancer drugs even after announcing an $...

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

I’m sure someone knows what that means.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 2. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Lilly's cancer therapy Lartruvo fails study, shares dropEli Lilly and Co said on Friday its cancer treatment Lartruvo, approved on an ac... Pfftt, stick to making coffee.
Source: Reuters - 🏆 2. / 97 Read more »

Lilly cancer drug fails key trial, will no longer be prescribedEli Lilly and Co said on Friday that its cancer treatment Lartruvo, which had wo... They should just make and sell pastries. That's what it looks like they do from that logo. Maybe it needs a dose of chemo. So here’s 1 example of why drugs cost so much. For every one that succeeds, 99 fail - after $B invested in research. For Lilly to continue investing in research, cost recovery has to be borne by the effective drugs. Need to look at this whole process.
Source: Reuters - 🏆 2. / 97 Read more »

Stocks making the biggest moves premarket: Tesla, CVS Health, Eli Lilly, Netflix & moreSome of the names on the move ahead of the open.
Source: CNBC - 🏆 12. / 72 Read more »

Eli Lilly shares slide premarket on news of failed trial for sarcoma treatment
Source: MarketWatch - 🏆 3. / 97 Read more »

Eli Lilly to Buy Loxo Oncology in Deal It Values at About $8 BillionEli Lilly said it is buying Loxo Oncology for $235 a share—a 68% premium from Friday’s closing price—in cash, a deal that expands the biopharmaceutical company’s oncology-treatment portfolio. They got cash like that lying around? Cancer is a good business it seems. Can we get Universal Health Care please Wow.let's spread cancer to everyone Wonder how much the cost of insulin will soar to finance this gamble
Source: WSJ - 🏆 98. / 63 Read more »

Eli Lilly to buy Loxo Oncology in $8 billion cancer pushThe pharmaceutical company says it is buying Loxo Oncology for $235 a share in cash, a deal that expands the company’s cancer-treatment portfolio.
Source: trtworld - 🏆 101. / 63 Read more »

Eli Lilly to spend about $8B on Loxo OncologyEli Lilly is spending about $8 billion in cash to buy Loxo Oncology, as the drugmaker bulks up on cancer treatments that target certain gene abnormalities. Loxo Oncology could launch a drug next year and targets an abnormality that occurs in several tumor types, including some lung and... Hmm...Another Individual Attempting a Monopoly? If you want to know why we do not have a cure for cancer it is because this amount of money is exchanging hands. Treat not cure.
Source: ABC - 🏆 471. / 51 Read more »

Eli Lilly CEO: Loxo acquisition can help us treat cancer globally'This is the future of cancer treatment, we believe.' Eli Lilly CEO David Ricks said that Loxo Oncology has 'harnessed the power of emerging science' and that Lilly's acquisition of Loxo can help treat cancer globally. For a price Never gonna happen...they make too much money off of giving everyone cancer then all the treatments and pills.
Source: CNBC - 🏆 12. / 72 Read more »